Use of plerixafor for hematopoietic stem cells mobilization in allograft donors

Use of plerixafor for hematopoietic stem cells mobilization in allograft donors

Unsuccessful mobilization of hematopoietic stem cells (HSCs) before apheresis in allograft donor is a factor adversely affecting the characteristics of the obtained cell product and, as a consequence, the therapy outcome. This study investigates the efficacy and safety of plerixafor as an additional...

Full description

Saved in:
Bibliographic Details
Main Authors: D. N. Balashov, E. E. Kurnikova, M. A. Maschan, Yu. V. Skvortsov, L. N. Shelikhova, P. E. Trakhtman, E. V. Boyakova, E. V. Skorobogatova, G. A. Novichkova, A. A. Maschan
Format: Article
Language:Russian
Published: ABV-press 2015-01-01
Series:Онкогематология
Subjects:
plerixafor
g-csf
allogeneic transplantation
hematopoietic stem cells
mobilization
alternative technology
donors
apheresis
efficacy
safety
side effects
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/128
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://oncohematology.abvpress.ru/ongm/article/view/128

Similar Items